THE TOP 10 GLOBAL FINE CHEMICALS COMPANIES - Industry overview, key trends, growth strategies, financial performance, and SWOT analysis

Date: July 22, 2010
Pages: 136
Price:
US$ 3,835.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T8092582D29EN
Leaflet:

Download PDF Leaflet

THE TOP 10 GLOBAL FINE CHEMICALS COMPANIES - Industry overview, key trends, growth strategies, financial performance, and SWOT analysis
Introduction

This report profiles the leading players in the global fine chemicals market. It analyzes the global fine chemicals industry in terms of market dynamics (market size and profitability), key M&A activity, current industry trends, and the competitive positioning of the leading 10 players in the market. It also includes a brief overview of other major players in the industry. RBCE0003

Scope of this research

Evaluate the financial performance and growth strategies of leading companies in the global fine chemicals market and review other leading players. Understand the segmentation of the fine chemicals market, including pharmaceutical and agrochemical intermediates, dyes, flavors and fragrances. Assess key partnerships and M&A activities that are shaping the future of the global fine chemicals industry and understand the issues affecting it. Identify key trends and opportunities in the global fine chemicals market and assess the market dynamics and profitability. Understand which companies will drive growth in the fine chemicals market through strategic analysis of strengths and weaknesses. Research and analysis highlights

The pharmaceutical industry has always been the largest market for the fine chemicals industry. Although the number of fine chemicals companies developing high-potency APIs has been limited, this segment has attracted many companies in recent years. Agrochemical intermediates represent the second largest category in the fine chemicals market.

Fine chemicals players with significant exposure to the generics segment are likely to face pressure on their profitability levels in the near future. However, the recent shift in focus toward biopharmaceutical products will expand the margin of this industry in coming years.

Outsourcing has become a key trend in this industry, fueled by the growing importance of biopharmaceutical and virtual pharma companies in low-cost destinations such as Asia. Outsourcing from biotech and pharmaceutical companies will strengthen the custom manufacturing industry in India and China.

Key reasons to purchase this research

What are the key trends of global fine chemicals industry and how have leading players in the market fared through the recent economic downturn? Who are the leading players in the market and what are their key strengths and weaknesses, and what threats and opportunities do they face? Which key partnerships and M&A activities will shape the future of the global fine chemicals market and which companies are driving growth? What are the growth strategies of leading fine chemical producers such as BASF, Lonza, DSM, Sumitomo Chemicals, Merck KGaA Chemicals, and Lanxess? Which companies are best positioned to succeed in the global fine chemicals market during 2009–14, and what are the current market dynamics?
The Top 10 Global Fine Chemicals Companies
Executive summary
Industry overview
BASF
Lonza
DSM
Sumitomo Chemical
Merck KGaA
Lanxess (Saltigo)
Sigma-Aldrich
Jubilant Organosys
Johnson Matthey
Evonik Chemicals

CHAPTER 1 INTRODUCTION

What is this report about?
Methodology

CHAPTER 2 INDUSTRY OVERVIEW

Summary
Fine chemicals – an overview
Different types of fine chemicals
Pharmaceutical intermediates
Agrochemical intermediates
Flavors and fragrances
Dyes and others
Market dynamics
Size and structure
Profitability
Competitive landscape
Manufacturing standards and their potential benefits
Potential benefits of the guideline
Key partnerships and M&A activity in the fine chemicals sector
Key trends
Advanced technologies
Increasing demand for HPAPIs
Relocation to emerging and fast growing markets
Increasing use of biotechnology and nanotechnology

CHAPTER 3 BASF

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Leading supplier of chemical intermediates
Verbund, an innovative approach
Diversified product portfolio
SWOT analysis

CHAPTER 4 LONZA

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Chemical manufacturing strengthens Lonza’s technology platform
Partnership with biopharmaceutical and chemical companies
SWOT analysis

CHAPTER 5 DSM

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Increasing R&D activity in emerging markets
Microreactors: a new technology for pharmaceutical production
SWOT analysis

CHAPTER 6 SUMITOMO CHEMICAL

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Strong progress in major R&D projects
Pursuing a new strategy of creative hybrid chemistry
Strong response to the EU’s REACH legislation for chemicals
Creation of next-generation chemical safety information management database
SWOT analysis

CHAPTER 7 MERCK KGAA CHEMICALS

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Merck KGaA and Millipore partnership for specialty products
New pharmaceutical production plant to increase Merck KGaA’s capacity in Germany
Stronger presence in India through acquisition of Bangalore Genei
Merck Serono to build its R&D operations in China
SWOT analysis

CHAPTER 8 LANXESS (SALTIGO)

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Expansion in BRIC countries
Advanced Intermediates segment
Custom manufacturing
SWOT analysis

CHAPTER 9 SIGMA-ALDRICH

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Strong focus on emerging markets
Partnerships and alliances
Targeting the high-growth biology segment
SWOT analysis

CHAPTER 10 JUBILANT ORGANOSYS

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Integrated business model
Strong R&D and manufacturing services for intermediates and APIs
Positioning as an outsourcing partner of choice
SWOT analysis

CHAPTER 11 JOHNSON MATTHEY

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Johnson Matthey’s Sustainability 2017 initiative
Strong market position in APIs and contract manufacturing services
SWOT analysis

CHAPTER 12 EVONIK CHEMICALS

Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Specialty chemicals remain a key focus area for Evonik
Strong commitment to custom manufacturing business
SWOT analysis

CHAPTER 13 OTHER MAJOR PLAYERS

Boehringer Ingelheim
Company overview
Recent financial performance
Divis Laboratories
Company overview
Recent financial performance
Pfizer CentreSource
Company overview
Recent financial performance
Cambrex
Company overview
Recent financial performance
Fabbrica Italiana Sintetici
Company overview
Recent financial performance
Appendix
Glossary
Index

LIST OF FIGURES

Figure 2.1: Fine chemicals and their usage
Figure 3.2: BASF SWOT analysis
Figure 4.3: Lonza business divisions
Figure 4.4: Lonza SWOT analysis
Figure 5.5: DSM business focus
Figure 5.6: DSM SWOT analysis
Figure 6.7: Sumitomo Chemical research laboratories
Figure 6.8: Sumitomo Chemical SWOT analysis
Figure 7.9: Merck KGaA Chemicals SWOT analysis
Figure 8.10: Saltigo SWOT analysis
Figure 9.11: Sigma-Aldrich SWOT analysis
Figure 10.12: Jubilant Organosys business segmentation
Figure 10.13: Jubilant Organosys SWOT analysis
Figure 11.14: Johnson Matthey business segmentation
Figure 11.15: Johnson Matthey SWOT analysis
Figure 12.16: Evonik Chemicals SWOT analysis

LIST OF TABLES

Table 2.1: Global fine chemicals market size, 2009–2015
Table 2.2: Leading 10 global fine chemicals companies, 2009
Table 3.3: BASF snapshot
Table 3.4: BASF financial performance by segment, 2009
Table 3.5: BASF chemical sales performance, 2009
Table 4.6: Lonza snapshot
Table 4.7: Lonza financial performance by operating segments, 2009
Table 5.8: DSM snapshot
Table 5.9: DSM key launches in 2009
Table 5.10: DSM R&D expenditure, 2009
Table 5.11: DSM financial performance by segment, 2009
Table 5.12: DSM fine chemicals performance by segment, 2009
Table 6.13: Sumitomo Chemical snapshot
Table 6.14: Sumitomo Chemical financial performance by operating segments, FY 2008
Table 6.15: Sumitomo Chemical financial performance during FY 2004–2008
Table 7.16: Merck KGaA Chemicals snapshot
Table 7.17: Merck KGaA sales performance, 2009
Table 7.18: Merck KGaA Chemicals segmentation sales performance, 2009
Table 8.19: Lanxess (Saltigo) snapshot
Table 8.20: Lanxess financial performance by operating segments, 2009
Table 9.21: Sigma-Aldrich snapshot
Table 9.22: Sigma-Aldrich financial performance by operating segments, 2009
Table 10.23: Jubilant Organosys snapshot
Table 10.24: Jubilant Organosys financial performance by operating segments, FY 2009
Table 10.25: Jubilant Organosys financial performance during FY 2005–2009
Table 10.26: PLSPS revenue distribution by segments, FY 2009
Table 10.27: CRAMS revenue distribution by segments, FY 2009
Table 11.28: Johnson Matthey snapshot
Table 11.29: Johnson Matthey financial performance by operating segments, FY 2008
Table 12.30: Evonik Industries snapshot
Table 12.31: Evonik Industries financial performance by operating segments, 2009
Table 12.32: Evonik Chemicals financial performance by segments, 2009
Table 13.33: Boehringer Ingelheim snapshot
Table 13.34: Boehringer Ingelheim financial performance by operating segments, 2009
Table 13.35: Divis Laboratories snapshot
Table 13.36: Divis Laboratories financial performance, FY 2008
Table 13.37: Pfizer CentreSource snapshot
Table 13.38: Cambrex snapshot
Table 13.39: Cambrex segmental revenue, 2009
Table 13.40: Fabbrica Italiana Sintetici snapshot
Skip to top


Ask Your Question

THE TOP 10 GLOBAL FINE CHEMICALS COMPANIES - Industry overview, key trends, growth strategies, financial performance, and SWOT analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: